Task: Answer Verification
Input (English): Question: Does prophylactic tetracycline diminish the severity of epidermal growth factor receptor ( EGFR ) inhibitor-induced rash : results from the North Central Cancer Treatment Group ( Supplementary N03CB )?
Answer: Although previous studies suggest otherwise, this randomized, double-blinded, placebo-controlled study did not find that tetracycline lessened rash incidence or severity in patients who were taking EGFR inhibitors.
Output (English): no